Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

379.01
Delayed Data
As of Feb 12
 +11.77 / +3.20%
Today’s Change
350.26
Today|||52-Week Range
605.93
-30.18%
Year-to-Date

Today’s Trading

Previous close367.24
Today’s open371.36
Day’s range365.13 - 379.04
Volume728,165
Average volume (3 months)871,545
Market cap$39.7B
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+79.80%
Earnings growth (this year)-0.41%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+45.55%
P/E ratio74.9
Price/Sales15.24
Price/Book--

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+1.43+2.42%
ALNYAlnylam Pharmaceutic...+2.59+4.55%
IONSIonis Pharmaceutical...+1.49+4.35%
ICLRICON PLC+0.74+1.12%
Data as of 4:02pm ET, 02/12/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)$2.65
Annual revenue (last year)$4.1B
Annual profit (last year)$636.1M
Net profit margin15.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts

Partner Offers